Literature DB >> 10570993

Extensive nucleotide variability within a 370 kb sequence from the central region of the major histocompatibility complex.

S Gaudieri1, J K Kulski, R L Dawkins, T Gojobori.   

Abstract

The recent availability of the genomic sequence spanning the central and telomeric end of the major histocompatibility complex (MHC) has allowed a detailed study of its organisation, gene content and level of nucleotide variability. Previous analyses of nucleotide variability in the MHC have focused on the coding regions of the human leukocyte antigen (HLA) Class I and II genes. Non-coding nucleotide variability has been considered a by-product of exonic diversity. However, with the advent of genomic sequencing, the extent of non-coding nucleotide variability within the MHC has just begun to be appreciated. In this study, we compared different human haplotypes in 370 kb of sequence in the central region of the MHC to show the following: 1. unusually high levels of non-coding nucleotide variability, up to 80 times greater than elsewhere in the genome; 2. non-coding nucleotide variability greater than 1% at nucleotide sites distant to the Class I genes; 3. nucleotide variability greater than 1% maintained over regions containing highly linked loci; and 4. distinct troughs and peaks in the level of nucleotide variability. We will discuss these observations in relation to a possible role of nucleotide variability in the organisation of the MHC.

Entities:  

Mesh:

Year:  1999        PMID: 10570993     DOI: 10.1016/s0378-1119(99)00255-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  SNP profile within the human major histocompatibility complex reveals an extreme and interrupted level of nucleotide diversity.

Authors:  S Gaudieri; R L Dawkins; K Habara; J K Kulski; T Gojobori
Journal:  Genome Res       Date:  2000-10       Impact factor: 9.043

2.  Genomic analysis reveals a duplication of eight rather than seven short consensus repeats in primate CR1 and CR1L: evidence for an additional set shared between CR1 and CR2.

Authors:  C A McLure; J F Williamson; B J Stewart; P J Keating; R L Dawkins
Journal:  Immunogenetics       Date:  2004-10-30       Impact factor: 2.846

3.  Nucleotide variability at G6pd and the signature of malarial selection in humans.

Authors:  Matthew A Saunders; Michael F Hammer; Michael W Nachman
Journal:  Genetics       Date:  2002-12       Impact factor: 4.562

4.  Comparative sequencing of human and chimpanzee MHC class I regions unveils insertions/deletions as the major path to genomic divergence.

Authors:  Tatsuya Anzai; Takashi Shiina; Natsuki Kimura; Kazuyo Yanagiya; Sakae Kohara; Atsuko Shigenari; Tetsushi Yamagata; Jerzy K Kulski; Taeko K Naruse; Yoshifumi Fujimori; Yasuhito Fukuzumi; Masaaki Yamazaki; Hiroyuki Tashiro; Chie Iwamoto; Yumi Umehara; Tadashi Imanishi; Alice Meyer; Kazuho Ikeo; Takashi Gojobori; Seiamak Bahram; Hidetoshi Inoko
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-10       Impact factor: 11.205

5.  Complete MHC haplotype sequencing for common disease gene mapping.

Authors:  C Andrew Stewart; Roger Horton; Richard J N Allcock; Jennifer L Ashurst; Alexey M Atrazhev; Penny Coggill; Ian Dunham; Simon Forbes; Karen Halls; Joanna M M Howson; Sean J Humphray; Sarah Hunt; Andrew J Mungall; Kazutoyo Osoegawa; Sophie Palmer; Anne N Roberts; Jane Rogers; Sarah Sims; Yu Wang; Laurens G Wilming; John F Elliott; Pieter J de Jong; Stephen Sawcer; John A Todd; John Trowsdale; Stephan Beck
Journal:  Genome Res       Date:  2004-05-12       Impact factor: 9.043

6.  Genetic analysis of completely sequenced disease-associated MHC haplotypes identifies shuffling of segments in recent human history.

Authors:  James A Traherne; Roger Horton; Anne N Roberts; Marcos M Miretti; Matthew E Hurles; C Andrew Stewart; Jennifer L Ashurst; Alexey M Atrazhev; Penny Coggill; Sophie Palmer; Jeff Almeida; Sarah Sims; Laurens G Wilming; Jane Rogers; Pieter J de Jong; Mary Carrington; John F Elliott; Stephen Sawcer; John A Todd; John Trowsdale; Stephan Beck
Journal:  PLoS Genet       Date:  2006-01-27       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.